Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jwarantak is an Ayurvedic proprietary herbo-mineral formulation developed by Vyas Pharmaceuticals. It is traditionally used as an antipyretic and anti-inflammatory agent to manage various types of fevers, including chronic, intermittent, and viral fevers, as well as associated symptoms like body aches and indigestion. The formulation is available in tablet and syrup forms. The tablet variant contains a blend of traditional Ayurvedic preparations and herbs, including Sarvajwarahar Loha, Mahasudarshan Ghana, Godanti Bhasma, Tankan Bhasma, Laxmivilas Abhrak, Yashtimadhu (licorice), Giloy (Guduchi), Saptaparna, Chirayata, Kutki, Talispatra, and Bhumi Amla. Jwarantak works by promoting sweating, aiding detoxification, boosting immunity, and supporting liver and digestive functions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Jwarantak.